Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ead1cb9dec5d78b0d99f8c93429b70a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7157fb48b55f44b048c0f3b3c3aa0d67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecf6f4b52feb1aecfd740c280e41aefe http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a095c4c0dc763f9b8de87f38dcd35c18 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
filingDate |
2009-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0aa8a8b7008c776974f1578d86d61ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10ddf54b21ce41f8e976749e23dae114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14263cffdff2d2fa751a6a25b5d99eda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee725f5f8336aba6e8fa618aa46d77bf |
publicationDate |
2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012027805-A1 |
titleOfInvention |
Controlled-Released Peptide Formulations |
abstract |
Described herein are methods and compositions for modulating the release and/or drug loading characteristics of encapsulated bioactive agents in polymer-based delivery systems via direct modification of the isoelectric point and/or net charge of the bioactive agent. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016292322-A1 |
priorityDate |
2008-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |